Schinazi RF - Search Results

1

HIV nucleoside reverse transcriptase inhibitors.

Amblard F, Patel D, Michailidis E, Coats SJ, Kasthuri M, Biteau N, Tber Z, Ehteshami M, Schinazi RF. Amblard F, et al. Among authors: schinazi rf. Eur J Med Chem. 2022 Oct 5;240:114554. doi: 10.1016/j.ejmech.2022.114554. Epub 2022 Jun 20. Eur J Med Chem. 2022. PMID: 35792384 Review.

2

Synthesis, characterization, and anti-human immunodeficiency virus activity of water-soluble salts of polyoxotungstate anions with covalently attached organic groups.

Weeks MS, Hill CL, Schinazi RF. Weeks MS, et al. Among authors: schinazi rf. J Med Chem. 1992 Apr 3;35(7):1216-21. doi: 10.1021/jm00085a008. J Med Chem. 1992. PMID: 1373190

3

Synthesis and antiviral activity of various 3'-azido analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1, HTLV-III/LAV).

Lin TS, Guo JY, Schinazi RF, Chu CK, Xiang JN, Prusoff WH. Lin TS, et al. Among authors: schinazi rf. J Med Chem. 1988 Feb;31(2):336-40. doi: 10.1021/jm00397a011. J Med Chem. 1988. PMID: 3339606

4

Synthesis, characterization, and biological activity of a new potent class of anti-HIV agents, the peroxoniobium-substituted heteropolytungstates.

Kim GS, Judd DA, Hill CL, Schinazi RF. Kim GS, et al. Among authors: schinazi rf. J Med Chem. 1994 Mar 18;37(6):816-20. doi: 10.1021/jm00032a016. J Med Chem. 1994. PMID: 7511692

5

Synthesis and biological evaluation of 2',3'-didehydro-2',3'- dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase.

Shi J, McAtee JJ, Schlueter Wirtz S, Tharnish P, Juodawlkis A, Liotta DC, Schinazi RF. Shi J, et al. Among authors: schinazi rf. J Med Chem. 1999 Mar 11;42(5):859-67. doi: 10.1021/jm980510s. J Med Chem. 1999. PMID: 10072683

6

Mechanistic studies show that (-)-FTC-TP is a better inhibitor of HIV-1 reverse transcriptase than 3TC-TP.

Feng JY, Shi J, Schinazi RF, Anderson KS. Feng JY, et al. Among authors: schinazi rf. FASEB J. 1999 Sep;13(12):1511-7. doi: 10.1096/fasebj.13.12.1511. FASEB J. 1999. PMID: 10463941

7

Early detection of mixed mutations selected by antiretroviral agents in HIV-infected primary human lymphocytes.

Schinazi RF, Schlueter-Wirtz S, Stuyver L. Schinazi RF, et al. Antivir Chem Chemother. 2001;12 Suppl 1:61-5. Antivir Chem Chemother. 2001. PMID: 11594690

8

DPC 817: a cytidine nucleoside analog with activity against zidovudine- and lamivudine-resistant viral variants.

Schinazi RF, Mellors J, Bazmi H, Diamond S, Garber S, Gallagher K, Geleziunas R, Klabe R, Pierce M, Rayner M, Wu JT, Zhang H, Hammond J, Bacheler L, Manion DJ, Otto MJ, Stuyver L, Trainor G, Liotta DC, Erickson-Viitanen S. Schinazi RF, et al. Antimicrob Agents Chemother. 2002 May;46(5):1394-401. doi: 10.1128/AAC.46.5.1394-1401.2002. Antimicrob Agents Chemother. 2002. PMID: 11959574 Free PMC article.

9

Development of a pharmacodynamic model for HIV treatment with nucleoside reverse transcriptase and protease inhibitors.

Hurwitz SJ, Schinazi RF. Hurwitz SJ, et al. Among authors: schinazi rf. Antiviral Res. 2002 Nov;56(2):115-27. doi: 10.1016/s0166-3542(02)00103-1. Antiviral Res. 2002. PMID: 12367718

10

Probing the mechanistic consequences of 5-fluorine substitution on cytidine nucleotide analogue incorporation by HIV-1 reverse transcriptase.

Ray AS, Schinazi RF, Murakami E, Basavapathruni A, Shi J, Zorca SM, Chu CK, Anderson KS. Ray AS, et al. Among authors: schinazi rf. Antivir Chem Chemother. 2003 May;14(3):115-25. doi: 10.1177/095632020301400301. Antivir Chem Chemother. 2003. PMID: 14521328 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

606 results

Search Page